Global CAR-T Therapy Market Research Report 2022

Publisher Name :
Date: 29-Jul-2022
No. of pages: 93
Inquire Before Buying

CAR-T Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CAR-T Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- CD19

- CD22

- Other

Segment by Application

- Acute Lymphocytic Leukemia

- Diffuse Large B Cell Lymphoma

- Follicular Lymphoma

- Chronic Lymphocytic Leukemia

- Multiple Myeloma

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Novartis AG

- Kite Pharma

- Pfizer

- Juno Therapeutics

- Celgene Corporation

- CARsgen Therapeutics

- Sorrento Therapeutics

- Legend Biotech

- Atara Biotherapeutics

- Aurora Biopharma

- Autolus Therapeutics PLC

- Bluebird

- Carina Biotech

Global CAR-T Therapy Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CD19
1.2.3 CD22
1.2.4 Other
1.3 Market by Application
1.3.1 Global CAR-T Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Acute Lymphocytic Leukemia
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Chronic Lymphocytic Leukemia
1.3.6 Multiple Myeloma
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Therapy Market Perspective (2017-2028)
2.2 CAR-T Therapy Growth Trends by Region
2.2.1 CAR-T Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 CAR-T Therapy Historic Market Size by Region (2017-2022)
2.2.3 CAR-T Therapy Forecasted Market Size by Region (2023-2028)
2.3 CAR-T Therapy Market Dynamics
2.3.1 CAR-T Therapy Industry Trends
2.3.2 CAR-T Therapy Market Drivers
2.3.3 CAR-T Therapy Market Challenges
2.3.4 CAR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Therapy Players by Revenue
3.1.1 Global Top CAR-T Therapy Players by Revenue (2017-2022)
3.1.2 Global CAR-T Therapy Revenue Market Share by Players (2017-2022)
3.2 Global CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR-T Therapy Revenue
3.4 Global CAR-T Therapy Market Concentration Ratio
3.4.1 Global CAR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy Revenue in 2021
3.5 CAR-T Therapy Key Players Head office and Area Served
3.6 Key Players CAR-T Therapy Product Solution and Service
3.7 Date of Enter into CAR-T Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Therapy Breakdown Data by Type
4.1 Global CAR-T Therapy Historic Market Size by Type (2017-2022)
4.2 Global CAR-T Therapy Forecasted Market Size by Type (2023-2028)
5 CAR-T Therapy Breakdown Data by Application
5.1 Global CAR-T Therapy Historic Market Size by Application (2017-2022)
5.2 Global CAR-T Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America CAR-T Therapy Market Size (2017-2028)
6.2 North America CAR-T Therapy Market Size by Country (2017-2022)
6.3 North America CAR-T Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe CAR-T Therapy Market Size (2017-2028)
7.2 Europe CAR-T Therapy Market Size by Country (2017-2022)
7.3 Europe CAR-T Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Therapy Market Size (2017-2028)
8.2 Asia-Pacific CAR-T Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific CAR-T Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America CAR-T Therapy Market Size (2017-2028)
9.2 Latin America CAR-T Therapy Market Size by Country (2017-2022)
9.3 Latin America CAR-T Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Therapy Market Size (2017-2028)
10.2 Middle East & Africa CAR-T Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa CAR-T Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Therapy Introduction
11.1.4 Novartis AG Revenue in CAR-T Therapy Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Therapy Introduction
11.2.4 Kite Pharma Revenue in CAR-T Therapy Business (2017-2022)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer CAR-T Therapy Introduction
11.3.4 Pfizer Revenue in CAR-T Therapy Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics CAR-T Therapy Introduction
11.4.4 Juno Therapeutics Revenue in CAR-T Therapy Business (2017-2022)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation CAR-T Therapy Introduction
11.5.4 Celgene Corporation Revenue in CAR-T Therapy Business (2017-2022)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Detail
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics CAR-T Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in CAR-T Therapy Business (2017-2022)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Detail
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics CAR-T Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in CAR-T Therapy Business (2017-2022)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Detail
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech CAR-T Therapy Introduction
11.8.4 Legend Biotech Revenue in CAR-T Therapy Business (2017-2022)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics CAR-T Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in CAR-T Therapy Business (2017-2022)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Detail
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma CAR-T Therapy Introduction
11.10.4 Aurora Biopharma Revenue in CAR-T Therapy Business (2017-2022)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Detail
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC CAR-T Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2017-2022)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Detail
11.12.2 Bluebird Business Overview
11.12.3 Bluebird CAR-T Therapy Introduction
11.12.4 Bluebird Revenue in CAR-T Therapy Business (2017-2022)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Detail
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech CAR-T Therapy Introduction
11.13.4 Carina Biotech Revenue in CAR-T Therapy Business (2017-2022)
11.13.5 Carina Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of CD19
Table 3. Key Players of CD22
Table 4. Key Players of Other
Table 5. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global CAR-T Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global CAR-T Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global CAR-T Therapy Market Share by Region (2017-2022)
Table 9. Global CAR-T Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global CAR-T Therapy Market Share by Region (2023-2028)
Table 11. CAR-T Therapy Market Trends
Table 12. CAR-T Therapy Market Drivers
Table 13. CAR-T Therapy Market Challenges
Table 14. CAR-T Therapy Market Restraints
Table 15. Global CAR-T Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global CAR-T Therapy Market Share by Players (2017-2022)
Table 17. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2021)
Table 18. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CAR-T Therapy Product Solution and Service
Table 22. Date of Enter into CAR-T Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global CAR-T Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global CAR-T Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global CAR-T Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global CAR-T Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global CAR-T Therapy Revenue Market Share by Application (2017-2022)
Table 30. Global CAR-T Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global CAR-T Therapy Revenue Market Share by Application (2023-2028)
Table 32. North America CAR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America CAR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe CAR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe CAR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific CAR-T Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific CAR-T Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America CAR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America CAR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa CAR-T Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa CAR-T Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Novartis AG Company Detail
Table 43. Novartis AG Business Overview
Table 44. Novartis AG CAR-T Therapy Product
Table 45. Novartis AG Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 46. Novartis AG Recent Development
Table 47. Kite Pharma Company Detail
Table 48. Kite Pharma Business Overview
Table 49. Kite Pharma CAR-T Therapy Product
Table 50. Kite Pharma Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 51. Kite Pharma Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer CAR-T Therapy Product
Table 55. Pfizer Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Juno Therapeutics Company Detail
Table 58. Juno Therapeutics Business Overview
Table 59. Juno Therapeutics CAR-T Therapy Product
Table 60. Juno Therapeutics Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 61. Juno Therapeutics Recent Development
Table 62. Celgene Corporation Company Detail
Table 63. Celgene Corporation Business Overview
Table 64. Celgene Corporation CAR-T Therapy Product
Table 65. Celgene Corporation Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 66. Celgene Corporation Recent Development
Table 67. CARsgen Therapeutics Company Detail
Table 68. CARsgen Therapeutics Business Overview
Table 69. CARsgen Therapeutics CAR-T Therapy Product
Table 70. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 71. CARsgen Therapeutics Recent Development
Table 72. Sorrento Therapeutics Company Detail
Table 73. Sorrento Therapeutics Business Overview
Table 74. Sorrento Therapeutics CAR-T Therapy Product
Table 75. Sorrento Therapeutics Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 76. Sorrento Therapeutics Recent Development
Table 77. Legend Biotech Company Detail
Table 78. Legend Biotech Business Overview
Table 79. Legend Biotech CAR-T Therapy Product
Table 80. Legend Biotech Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 81. Legend Biotech Recent Development
Table 82. Atara Biotherapeutics Company Detail
Table 83. Atara Biotherapeutics Business Overview
Table 84. Atara Biotherapeutics CAR-T Therapy Product
Table 85. Atara Biotherapeutics Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 86. Atara Biotherapeutics Recent Development
Table 87. Aurora Biopharma Company Detail
Table 88. Aurora Biopharma Business Overview
Table 89. Aurora Biopharma CAR-T Therapy Product
Table 90. Aurora Biopharma Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 91. Aurora Biopharma Recent Development
Table 92. Autolus Therapeutics PLC Company Detail
Table 93. Autolus Therapeutics PLC Business Overview
Table 94. Autolus Therapeutics PLC CAR-T TherapyProduct
Table 95. Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 96. Autolus Therapeutics PLC Recent Development
Table 97. Bluebird Company Detail
Table 98. Bluebird Business Overview
Table 99. Bluebird CAR-T TherapyProduct
Table 100. Bluebird Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 101. Bluebird Recent Development
Table 102. Carina Biotech Company Detail
Table 103. Carina Biotech Business Overview
Table 104. Carina Biotech CAR-T TherapyProduct
Table 105. Carina Biotech Revenue in CAR-T Therapy Business (2017-2022) & (US$ Million)
Table 106. Carina Biotech Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR-T Therapy Market Share by Type: 2021 VS 2028
Figure 2. CD19 Features
Figure 3. CD22 Features
Figure 4. Other Features
Figure 5. Global CAR-T Therapy Market Share by Application in 2021 & 2028
Figure 6. Acute Lymphocytic Leukemia Case Studies
Figure 7. Diffuse Large B Cell Lymphoma Case Studies
Figure 8. Follicular Lymphoma Case Studies
Figure 9. Chronic Lymphocytic Leukemia Case Studies
Figure 10. Multiple Myeloma Case Studies
Figure 11. Other Case Studies
Figure 12. CAR-T Therapy Report Years Considered
Figure 13. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global CAR-T Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global CAR-T Therapy Market Share by Region: 2021 VS 2028
Figure 16. Global CAR-T Therapy Market Share by Players in 2021
Figure 17. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2021
Figure 19. North America CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America CAR-T Therapy Market Share by Country (2017-2028)
Figure 21. United States CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe CAR-T Therapy Market Share by Country (2017-2028)
Figure 25. Germany CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific CAR-T Therapy Market Share by Region (2017-2028)
Figure 33. China CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America CAR-T Therapy Market Share by Country (2017-2028)
Figure 41. Mexico CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa CAR-T Therapy Market Share by Country (2017-2028)
Figure 45. Turkey CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Novartis AG Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 48. Kite Pharma Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 49. Pfizer Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 50. Juno Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 51. Celgene Corporation Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 52. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 53. Sorrento Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 54. Legend Biotech Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 55. Atara Biotherapeutics Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 56. Aurora Biopharma Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 57. Autolus Therapeutics PLC Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 58. Bluebird Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 59. Carina Biotech Revenue Growth Rate in CAR-T Therapy Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs